Regenerative Medical Technology (RMTG) Interest Coverage Ratio (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Interest Coverage Ratio of 0.1 for Q1 2026, down 30.37% year-over-year from 0.15 in Q1 2025, and up 168.76% quarter-over-quarter from 0.15 in Q4 2025.
Regenerative Medical Technology (RMTG) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 0.1 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 30.37% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.09 (down 228.76% YoY), while the FY2025 annual figure was 0.11, down 931.87% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.1, up from 0.15 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.37 in Q4 2024, with the low at 136507.56 in Q4 2022.
- The 5-year median for Interest Coverage Ratio is 0.13 (2025), against an average of 8039.26.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio slumped 45620808.78% in 2022, then jumped 1242.1% in 2024.
- Regenerative Medical Technology's Interest Coverage Ratio stood at 136507.56 in 2022, then soared by 100.0% to 0.03 in 2023, then surged by 1242.1% to 0.37 in 2024, then tumbled by 140.87% to 0.15 in 2025, then jumped by 168.76% to 0.1 in 2026.
- Business Quant data shows RMTG's Interest Coverage Ratio at 0.1 in Q1 2026, 0.15 in Q4 2025, and 0.13 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.24 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | -0.11 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | -0.05 |
| Jun 30, 2023 | -158.75 |
| Mar 31, 2023 | -0.15 |
| Dec 31, 2022 | -136,507.56 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.48 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | -10.02 |
| Jun 30, 2021 | -0.58 |